tirzepatide will insurance cover glucagon‑like peptide‑1 (GLP‑1) receptor agonist therapy such as semaglutide or for a patient with morbid obesity (BMI ≥40 kg/m² or ≥35 kg/m² with comorbidities)? Welcome to Mounjaro® (tirzepatide injection)

The drug is based on a molecule called semaglutide, which mimics the structure of a hormone that naturally occurs in our bodies called glucagon-like peptide 1 (GLP-1)

Selected diagnoses included T2DM/nonspecific DM, overweight/obesity, hypertension, heart failure, hyperlipidemia, and atherosclerotic CVD

GLP-1 agonists Drug Class Insights The Drug Class Insights section will provide comprehensive information on Glucagon-like Peptide-1 (GLP-1) Agonists as a class

The delayed gastric emptying creates a sensation of fullness that persists longer after meals, though this effect may attenuate over time with continued use

Are online peptide sellers safe